William Blair reduced their Q1 2026 EPS estimates for Bristol-Myers Squibb in a research report issued to clients and ...

William Blair reduced their Q1 2025 earnings per share (EPS) estimates for Sapiens International in a report released on Tuesday, February 18th. William Blair analyst D. Becker now anticipates that ...

Fintel reports that on February 21, 2025, William Blair downgraded their outlook for Parsons (NYSE:PSN) from Outperform to Market Perform. Analyst Price Forecast Suggests 97.12% Upside As of February ...

The memo, and the surrounding uncertainty, caused investment bank William Blair to downgrade a wide number of companies, including Booz Allen, CACI, Leidos, and General Dynamics, to market perform ...

Friday looked set to be a crucial day for Palantir Technologies stock after its two-day 15% slump as investors assessed ...

William Blair downgrades Booz Allen, CACI International, Leidos, Parsons and General Dynamics on the heightened risk of ...

William Blair downgraded Booz Allen (BAH) to Market Perform from Outperform.Discover the Best Stocks and Maximize Your Portfolio: See what ...

Repligen Corp (NASDAQ:RGEN) released its fourth-quarter adjusted EPS of 44 cents on Tuesday, down from 48 cents a year ago ...

For investors looking for opportunities in fintech, SoFi presents an interesting case. Here's where analysts think the stock ...

William Blair analyst Arjun Bhatia maintained a Buy rating on Radcom (RDCM – Research Report) today. The company’s shares opened today at ...

Selma Blair exclusively opened up to Us Weekly about how she’s built up her confidence as she returns to Hollywood amid her ...